BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14973117)

  • 21. Targeting the endothelin axis in human melanoma: combination of endothelin receptor antagonism and alkylating agents.
    Berger Y; Bernasconi CC; Juillerat-Jeanneret L
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1111-9. PubMed ID: 16741059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronan-binding protein 1 (HABP1/p32/gC1qR) induces melanoma cell migration and tumor growth by NF-kappa B dependent MMP-2 activation through integrin α(v)β(3) interaction.
    Prakash M; Kale S; Ghosh I; Kundu GC; Datta K
    Cell Signal; 2011 Oct; 23(10):1563-77. PubMed ID: 21627988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional endothelin ET B receptors are selectively expressed in human oligodendrogliomas.
    Anguelova E; Beuvon F; Leonard N; Chaverot N; Varlet P; Couraud PO; Daumas-Duport C; Cazaubon S
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):77-88. PubMed ID: 15950764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade.
    Spiers JP; Kelso EJ; Siah WF; Edge G; Song G; McDermott BJ; Hennessy M
    J Hypertens; 2005 Sep; 23(9):1717-24. PubMed ID: 16093917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
    Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
    J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration.
    Takino T; Miyamori H; Watanabe Y; Yoshioka K; Seiki M; Sato H
    Cancer Res; 2004 Feb; 64(3):1044-9. PubMed ID: 14871836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The endothelin axis: a novel target for pharmacotherapy of female malignancies.
    Smollich M; Wülfing P
    Curr Vasc Pharmacol; 2007 Jul; 5(3):239-48. PubMed ID: 17627567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin axis induces metalloproteinase activation and invasiveness in human lymphatic endothelial cells.
    Spinella F; Caprara V; Garrafa E; Di Castro V; Rosanò L; Natali PG; Bagnato A
    Can J Physiol Pharmacol; 2010 Aug; 88(8):782-7. PubMed ID: 20725135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices.
    Ntayi C; Lorimier S; Berthier-Vergnes O; Hornebeck W; Bernard P
    Exp Cell Res; 2001 Oct; 270(1):110-8. PubMed ID: 11597133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.
    Felding-Habermann B; Fransvea E; O'Toole TE; Manzuk L; Faha B; Hensler M
    Clin Exp Metastasis; 2002; 19(5):427-36. PubMed ID: 12198771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interruption of endothelin signaling modifies membrane type 1 matrix metalloproteinase activity during ischemia and reperfusion.
    Deschamps AM; Zavadzkas J; Murphy RL; Koval CN; McLean JE; Jeffords L; Saunders SM; Sheats NJ; Stroud RE; Spinale FG
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H875-83. PubMed ID: 18065523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ARK5 is a tumor invasion-associated factor downstream of Akt signaling.
    Suzuki A; Lu J; Kusakai G; Kishimoto A; Ogura T; Esumi H
    Mol Cell Biol; 2004 Apr; 24(8):3526-35. PubMed ID: 15060171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion.
    Bartolomé RA; Molina-Ortiz I; Samaniego R; Sánchez-Mateos P; Bustelo XR; Teixidó J
    Cancer Res; 2006 Jan; 66(1):248-58. PubMed ID: 16397238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide production by endothelin-1 enhances astrocytic migration via the tyrosine nitration of matrix metalloproteinase-9.
    Wang HH; Hsieh HL; Yang CM
    J Cell Physiol; 2011 Sep; 226(9):2244-56. PubMed ID: 21660948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist: attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1/2 and nuclear factor-kappaB.
    Dschietzig T; Bartsch C; Richter C; Laule M; Baumann G; Stangl K
    Circ Res; 2003 Jan; 92(1):32-40. PubMed ID: 12522118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma.
    Klisovic DD; Klisovic MI; Effron D; Liu S; Marcucci G; Katz SE
    Melanoma Res; 2005 Jun; 15(3):147-53. PubMed ID: 15917695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elastin-derived peptides upregulate matrix metalloproteinase-2-mediated melanoma cell invasion through elastin-binding protein.
    Ntayi C; Labrousse AL; Debret R; Birembaut P; Bellon G; Antonicelli F; Hornebeck W; Bernard P
    J Invest Dermatol; 2004 Feb; 122(2):256-65. PubMed ID: 15009703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes.
    He S; Prasanna G; Yorio T
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3737-45. PubMed ID: 17652746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.